Gaoliang Ouyang

7.5k citations
51 papers · 5.8k indexed · 1 hit paper · h-index 31

Gaoliang Ouyang

51 papers receiving 5.8k citations

Hit Papers

The activation of Akt/PKB signaling pathway and cell surv...1.6k200520262012201950010001.5k

Peers

Gaoliang Ouyang
Comparison fields: 5 of 131
  • Cancer Research 1.6k
  • Oncology 1.6k
  • Molecular Biology 3.3k
  • Molecular Medicine 218
  • Immunology and Allergy 234
Replace Peter E. Lobie with:
Peter E. Lobie China
Li Li China
Jian Huang China
Stéphane Plaisance Belgium
Ying Zhang China
Wei Cui China
Zhen Chen China
Isabel Fabregat Spain
Rui Li China
Gaoliang Ouyang relative to Peter E. Lobie China Peter E. Lobie's profile →
Citations per field
00.5×4.4×
Peter E. Lobie · 1×
Citations per year

Countries citing papers authored by Gaoliang Ouyang

Since Specialization
Citations

This map shows the geographic impact of Gaoliang Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaoliang Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaoliang Ouyang more than expected).

Fields of papers citing papers by Gaoliang Ouyang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaoliang Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaoliang Ouyang. The network helps show where Gaoliang Ouyang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gaoliang Ouyang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gaoliang Ouyang Line = papers co-authored together Gaoliang Ouyang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202420
2 20239
3 20236
4 201711
5 201753
6 2016127
7 201551
8 2015123
9 201419
10 201355
11 2011157
12 201086
13 2009274
14 2009104
15 2009372
16 200863
17 200872
18
The activation of Akt/PKB signaling pathway and cell survivalbreakdown →
20051563
19 2005194
20 2004470

About Gaoliang Ouyang

Gaoliang Ouyang is a scholar working on Cancer Research, Oncology and Cardiology and Cardiovascular Medicine, having authored 51 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (15 papers), Peptidase Inhibition and Analysis (9 papers), Cancer Cells and Metastasis (7 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Epigenetics and DNA Methylation (5 papers) and Signaling Pathways in Disease (5 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (1.6k citations) and Molecular Biology (3.3k citations). Gaoliang Ouyang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shideng Bao, Gang Song, Kai Ruan, Xiaoguang Fang, Yubin Mao, Zhengjie Huang, Luming Yao, Tiantian Wu, Min Liu and Chaoyong Yang. Their work appears in journals such as Nature Communications, The Journal of Experimental Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026